Pourkhodadad Soheila, Oryan Shahrbanoo, Hadipour Mohammad Mehdi, Kaka Gholamreza, Sadraie Seyed Homayoon
Department of Animal Physiology, Faculty of Biology, Kharazmi University, Tehran, Iran.
Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Basic Clin Neurosci. 2021 Nov-Dec;12(6):777-788. doi: 10.32598/bcn.2021.1727.1. Epub 2021 Nov 1.
Spinal Cord Injury (SCI) is a global public health issue that results in extensive neuronal degeneration, axonal and myelin loss, and severe functional deficits. Neurotrophic factors are a potential treatment for reducing secondary damage, promoting axon growth; they are responsible for inducing myelination after injury. Olfactory Ensheathing Cells (OECs) and minocycline have promoted locomotor function after SCI. The present study investigated the neuroprotective effects of combined treatment with minocycline and OECs on spinal cord injury related to Brain-Derived Neurotrophic Factor (BDNF) and Glial Derived Neurotrophic Factor (GDNF) expressions after SCI.
Adult female rats were used to experimental SCI by weight compression method. Rats received an intraperitoneal minocycline injection (90 mg/kg) immediately after SCI and 24 h after injury. OECs were transplanted one week after the injury. The hindlimb function was assessed using Basso Beattie Bresnahan (BBB) locomotor rating scale and Electromyography (EMG). After 5 weeks, the spinal cord segment centered at the injury site was removed for histopathological analysis. Immunohistological and western blot assays were performed to observe the expression of NeuN, BDNF, GDNF, and Myelin Basic Protein (MBP).
SCI induced the loss of locomotor function with decreased BDNF and GDNF expressions in the injury site. Minocycline+OECs increased the score of the BBB locomotor scale and increased spared tissue in the injury site. Immunohistochemical results suggested that NeuN expression significantly increased in the minocycline+OECs group than other groups. Moreover, electromyography amplitude in treated rats was increased compared to the control group. BDNF, GDNF, and MBP expressions and the number of ventral motor neurons increased further by minocycline+OECs in SCI rats.
The present study provides evidence that minocycline may facilitate recovery of locomotor function by OECs by increasing BDNF and GDNF expressions following SCI.
Combined treatment with Minocycline and OECs increased the locomotor function.The results showed that BDNF and GDNF expression increased by combined treatment with minocycline and OECs.
This study examined the effect of combined treatment with minocycline and olfactory ensheathing cell on the BDNF and GDNF expression after spinal cord injury model in rat. The results showed that injection of minocycline before transplantation of OECs enhances expression of neurotrophic factors that lead to an appropriate environment for transplanted OECs and increases neuronal survival that promotes tissue sparing and functional recovery.
脊髓损伤(SCI)是一个全球性的公共卫生问题,会导致广泛的神经元变性、轴突和髓鞘丢失以及严重的功能缺陷。神经营养因子是减少继发性损伤、促进轴突生长的一种潜在治疗方法;它们负责损伤后诱导髓鞘形成。嗅鞘细胞(OECs)和米诺环素已促进脊髓损伤后的运动功能。本研究调查了米诺环素和OECs联合治疗对脊髓损伤后与脑源性神经营养因子(BDNF)和胶质细胞源性神经营养因子(GDNF)表达相关的神经保护作用。
成年雌性大鼠采用重量压迫法进行实验性脊髓损伤。大鼠在脊髓损伤后立即腹腔注射米诺环素(90mg/kg),并在损伤后24小时再次注射。损伤一周后移植OECs。使用Basso Beattie Bresnahan(BBB)运动评分量表和肌电图(EMG)评估后肢功能。5周后,取出以损伤部位为中心的脊髓节段进行组织病理学分析。进行免疫组织化学和蛋白质印迹分析以观察NeuN、BDNF、GDNF和髓鞘碱性蛋白(MBP)的表达。
脊髓损伤导致运动功能丧失,损伤部位BDNF和GDNF表达降低。米诺环素+OECs增加了BBB运动量表评分,并增加了损伤部位的 spared组织。免疫组织化学结果表明,米诺环素+OECs组的NeuN表达明显高于其他组。此外,与对照组相比,治疗大鼠的肌电图振幅增加。米诺环素+OECs使脊髓损伤大鼠的BDNF、GDNF和MBP表达以及腹侧运动神经元数量进一步增加。
本研究提供了证据表明,米诺环素可能通过增加脊髓损伤后BDNF和GDNF的表达,促进OECs介导的运动功能恢复。
米诺环素和OECs联合治疗可提高运动功能。结果表明,米诺环素和OECs联合治疗可增加BDNF和GDNF的表达。
本研究检测了米诺环素和嗅鞘细胞联合治疗对大鼠脊髓损伤模型后BDNF和GDNF表达的影响。结果表明,在移植OECs之前注射米诺环素可增强神经营养因子的表达,为移植的OECs创造适宜的环境,并增加神经元存活,从而促进组织保留和功能恢复。